Kidney Transplant in the Era of Modern Therapy for Multiple Myeloma

Janna L. Huskey, Raymond L. Heilman, Hasan Khamash, Rafael Fonseca

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Chronic kidney disease is common in patients with multiple myeloma. Historically, individuals with end-stage renal disease and multiple myeloma did poorly with renal transplantation due to higher mortality rates from the malignancy itself or associated comorbidities. However, over the past 2 decades, there have been significant advances in the treatment of multiple myeloma with the advent of new therapeutic agents resulting in an improvement of long-term survival. As a result, more individuals with multiple myeloma are being referred for kidney transplantation, especially those with good functional capacity and minimal comorbidities. Recent literature has suggested that certain patients with multiple myeloma can successfully undergo renal transplantation after stem transplantation with consideration for maintenance therapy, although caution should be used with immunomodulating drugs due to the anecdotally reported risk of acute rejection. Therefore, having a multidisciplinary approach with the transplant team and hematology both before and after transplant is crucial in maximizing the chance of success for these individuals. This review summarizes the literature on renal transplantation in patients with multiple myeloma as well as the therapeutic advancements that have occurred which may allow certain patients to undergo successful transplantation.

Original languageEnglish (US)
Pages (from-to)1994-2001
Number of pages8
JournalTransplantation
Volume102
Issue number12
DOIs
StatePublished - Dec 1 2018

Fingerprint

Multiple Myeloma
Transplants
Kidney
Kidney Transplantation
Comorbidity
Therapeutics
Transplantation
Hematology
Chronic Renal Insufficiency
Chronic Kidney Failure
Survival
Mortality
Pharmaceutical Preparations
Neoplasms

ASJC Scopus subject areas

  • Transplantation

Cite this

Kidney Transplant in the Era of Modern Therapy for Multiple Myeloma. / Huskey, Janna L.; Heilman, Raymond L.; Khamash, Hasan; Fonseca, Rafael.

In: Transplantation, Vol. 102, No. 12, 01.12.2018, p. 1994-2001.

Research output: Contribution to journalReview article

Huskey, Janna L. ; Heilman, Raymond L. ; Khamash, Hasan ; Fonseca, Rafael. / Kidney Transplant in the Era of Modern Therapy for Multiple Myeloma. In: Transplantation. 2018 ; Vol. 102, No. 12. pp. 1994-2001.
@article{b053de8c507343eba78e01b0f51d1a7d,
title = "Kidney Transplant in the Era of Modern Therapy for Multiple Myeloma",
abstract = "Chronic kidney disease is common in patients with multiple myeloma. Historically, individuals with end-stage renal disease and multiple myeloma did poorly with renal transplantation due to higher mortality rates from the malignancy itself or associated comorbidities. However, over the past 2 decades, there have been significant advances in the treatment of multiple myeloma with the advent of new therapeutic agents resulting in an improvement of long-term survival. As a result, more individuals with multiple myeloma are being referred for kidney transplantation, especially those with good functional capacity and minimal comorbidities. Recent literature has suggested that certain patients with multiple myeloma can successfully undergo renal transplantation after stem transplantation with consideration for maintenance therapy, although caution should be used with immunomodulating drugs due to the anecdotally reported risk of acute rejection. Therefore, having a multidisciplinary approach with the transplant team and hematology both before and after transplant is crucial in maximizing the chance of success for these individuals. This review summarizes the literature on renal transplantation in patients with multiple myeloma as well as the therapeutic advancements that have occurred which may allow certain patients to undergo successful transplantation.",
author = "Huskey, {Janna L.} and Heilman, {Raymond L.} and Hasan Khamash and Rafael Fonseca",
year = "2018",
month = "12",
day = "1",
doi = "10.1097/TP.0000000000002449",
language = "English (US)",
volume = "102",
pages = "1994--2001",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - Kidney Transplant in the Era of Modern Therapy for Multiple Myeloma

AU - Huskey, Janna L.

AU - Heilman, Raymond L.

AU - Khamash, Hasan

AU - Fonseca, Rafael

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Chronic kidney disease is common in patients with multiple myeloma. Historically, individuals with end-stage renal disease and multiple myeloma did poorly with renal transplantation due to higher mortality rates from the malignancy itself or associated comorbidities. However, over the past 2 decades, there have been significant advances in the treatment of multiple myeloma with the advent of new therapeutic agents resulting in an improvement of long-term survival. As a result, more individuals with multiple myeloma are being referred for kidney transplantation, especially those with good functional capacity and minimal comorbidities. Recent literature has suggested that certain patients with multiple myeloma can successfully undergo renal transplantation after stem transplantation with consideration for maintenance therapy, although caution should be used with immunomodulating drugs due to the anecdotally reported risk of acute rejection. Therefore, having a multidisciplinary approach with the transplant team and hematology both before and after transplant is crucial in maximizing the chance of success for these individuals. This review summarizes the literature on renal transplantation in patients with multiple myeloma as well as the therapeutic advancements that have occurred which may allow certain patients to undergo successful transplantation.

AB - Chronic kidney disease is common in patients with multiple myeloma. Historically, individuals with end-stage renal disease and multiple myeloma did poorly with renal transplantation due to higher mortality rates from the malignancy itself or associated comorbidities. However, over the past 2 decades, there have been significant advances in the treatment of multiple myeloma with the advent of new therapeutic agents resulting in an improvement of long-term survival. As a result, more individuals with multiple myeloma are being referred for kidney transplantation, especially those with good functional capacity and minimal comorbidities. Recent literature has suggested that certain patients with multiple myeloma can successfully undergo renal transplantation after stem transplantation with consideration for maintenance therapy, although caution should be used with immunomodulating drugs due to the anecdotally reported risk of acute rejection. Therefore, having a multidisciplinary approach with the transplant team and hematology both before and after transplant is crucial in maximizing the chance of success for these individuals. This review summarizes the literature on renal transplantation in patients with multiple myeloma as well as the therapeutic advancements that have occurred which may allow certain patients to undergo successful transplantation.

UR - http://www.scopus.com/inward/record.url?scp=85056803988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056803988&partnerID=8YFLogxK

U2 - 10.1097/TP.0000000000002449

DO - 10.1097/TP.0000000000002449

M3 - Review article

C2 - 30211830

AN - SCOPUS:85056803988

VL - 102

SP - 1994

EP - 2001

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 12

ER -